Aerie Pharmaceuticals, Inc
AERI NASDAQ

AERI
Aerie Pharmaceuticals, Inc NASDAQ
Trade now
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Trade now

Financial statements

An in-depth look to Aerie Pharmaceuticals, Inc operating, investing, and financing activities

AERI free cash flow for Q1 21 is -28.98M. For 2020, AERI free cash flow was -61.78M and operating cash flow was -58.68M.

TTM
Cash from operating activities
Funds from operations
Changes in working capital
Cash from investing activities
Purchase/sale of business, net
Purchase/sale of investments, net
Capital expenditures
Other investing cash flow items, total
Cash from financing activities
Issuance/retirement of stock, net
Issuance/retirement of debt, net
Total cash dividends paid
Other financing cash flow items, total
Free cash flow